Results 131 to 140 of about 38,664 (219)

γ-Secretase [PDF]

Science-Business eXchange, 2010
openaire   +1 more source

Amyloid Alpha: The Neglected Cousin of Amyloid Beta. [PDF]

Chembiochem
Raskatov JA.
europepmc   +1 more source

The PDE5 inhibitor vardenafil enhances glutamatergic transmission through amyloid-beta and cellular prion protein. [PDF]

Neurotherapeutics
Kafi MAA, Passalacqua M, Villa V, Thellung S, Corsaro A, Grimaldi R, Spatola E, Florio T, Baldelli P, Ricciarelli R.   +9 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

In Silico Phosphoproteomic Analysis Reveals Divergent Regulation of Presenilin 1 and Presenilin 2. [PDF]

Neuromolecular Med
Begum S, De Alvarez JA, Manzoni C, Arber C, Lewis PA.   +4 more
europepmc   +1 more source

APP-C31 pathology as a target in neurodegenerative diseases. [PDF]

J Biomed Sci
Yip KC, Ho WF, Liu Y, Dawe GS.
europepmc   +1 more source

Turning defense into damage: HIV-driven amyloidogenesis and neurotoxicity. [PDF]

mBio
Gu F, Saed B, Naghavi MH.
europepmc   +1 more source

Genome-Wide CRISPR Screening Identifies Genetic Modulators of Amyloid Precursor Protein Processing. [PDF]

Int J Mol Sci
Li Y, Yao Y, Xu Z, Xiong Y, Zhang C, Yu L, Gao H, Fei T.   +7 more
europepmc   +1 more source

Small Molecule Therapeutics Targeting Amyloid-β in Alzheimer's Disease: Mechanisms, Clinical Progress, and Future Strategies. [PDF]

Exp Neurobiol
Park I, Lee D, Hong RS, Kim HY, Kim Y.
europepmc   +1 more source

A new era in neuropharmacology: assessing the efficacy and safety of novel anti-amyloid and non-amyloid drug targets for Alzheimer's disease. [PDF]

J Neurol
Hafez MM, Abbas HA, Shoman NA, Soubh AA, Aly O, Sallam MF, Seliem M, Malaak FA.   +7 more
europepmc   +1 more source